Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

V419 (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate \[Meningococcal Outer Membrane Protein Complex\], and Hepatitis B \[Recombinant\] Vaccine) 0.5 mL intramuscular injection at 2, 4, and 6 months of age

DAPTACEL™ 0.5 mL intramuscular injection at 15 months of age

PedvaxHIB™ 0.5 mL intramuscular injection at 15 months of age

Prevnar 13™ 0.5 mL intramuscular injection at 2, 4, 6, and 15 months of age

RotaTeq™ 2 mL oral dose at 2, 4, and 6 months of age

PENTACEL™ 0.5 mL intramuscular injection at 2, 4, and 6 months of age

Recombivax HB vaccine 0.5 mL intramuscular injection at 2 and 6 months of age

ActHIB™ 0.5 mL intramuscular injection at 15 months of age